Winner PK - Search Results

1

Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents.

McDonald SA, Hershey AD, Pearlman E, Lewis D, Winner PK, Rothner D, Linder SL, Runken MC, Richard NE, Derosier FJ. McDonald SA, et al. Among authors: winner pk. Headache. 2011 Oct;51(9):1374-87. doi: 10.1111/j.1526-4610.2011.01965.x. Epub 2011 Jul 28. Headache. 2011. PMID: 21797863 Clinical Trial.

2

Diagnosing migraine in the pediatric population.

Winner P, Hershey AD. Winner P, et al. Curr Pain Headache Rep. 2006 Oct;10(5):363-9. doi: 10.1007/s11916-006-0061-8. Curr Pain Headache Rep. 2006. PMID: 16945253 Review.

3

Epidemiology and diagnosis of migraine in children.

Winner P, Hershey AD. Winner P, et al. Curr Pain Headache Rep. 2007 Oct;11(5):375-82. doi: 10.1007/s11916-007-0220-6. Curr Pain Headache Rep. 2007. PMID: 17894928 Review.

4

Consistency of response to sumatriptan/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence.

Winner P, Linder S, Hershey AD. Winner P, et al. Headache. 2015 Apr;55(4):519-28. doi: 10.1111/head.12555. Headache. 2015. PMID: 25881677 Clinical Trial.

5

Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine.

Derosier FJ, Lewis D, Hershey AD, Winner PK, Pearlman E, Rothner AD, Linder SL, Goodman DK, Jimenez TB, Granberry WK, Runken MC. Derosier FJ, et al. Among authors: winner pk. Pediatrics. 2012 Jun;129(6):e1411-20. doi: 10.1542/peds.2011-2455. Epub 2012 May 14. Pediatrics. 2012. PMID: 22585767 Clinical Trial.

6

Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.

Winner P, Lewis D, Visser WH, Jiang K, Ahrens S, Evans JK; Rizatriptan Adolescent Study Group. Winner P, et al. Headache. 2002 Jan;42(1):49-55. doi: 10.1046/j.1526-4610.2002.02013.x. Headache. 2002. PMID: 12005275 Clinical Trial.

7

Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.

Visser WH, Winner P, Strohmaier K, Klipfel M, Peng Y, McCarroll K, Cady R, Lewis D, Nett R; Rizatriptan Protocol 059 and 061 Study Groups. Visser WH, et al. Headache. 2004 Oct;44(9):891-9. doi: 10.1111/j.1526-4610.2004.04171.x. Headache. 2004. PMID: 15447698 Clinical Trial.

8

The placebo responder rate in children and adolescents.

Lewis DW, Winner P, Wasiewski W. Lewis DW, et al. Headache. 2005 Mar;45(3):232-9. doi: 10.1111/j.1526-4610.2005.05050.x. Headache. 2005. PMID: 15836598 Review. No abstract available.

9

Use of the ICHD-II criteria in the diagnosis of pediatric migraine.

Hershey AD, Winner P, Kabbouche MA, Gladstein J, Yonker M, Lewis D, Pearlman E, Linder SL, Rothner AD, Powers SW. Hershey AD, et al. Headache. 2005 Nov-Dec;45(10):1288-97. doi: 10.1111/j.1526-4610.2005.00260.x. Headache. 2005. PMID: 16324160

10

Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.

Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J. Rothner AD, et al. Headache. 2006 Jan;46(1):101-9. doi: 10.1111/j.1526-4610.2006.00313.x. Headache. 2006. PMID: 16412157 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page